Low-dose imaging to guide removal of soft tissue tumors
Part of Cancer clinical trials.
This trial tests a newer imaging method that uses a very low dose of a contrast dye to help surgeons see and remove soft tissue tumors more precisely during surgery. It may help ensure the cancer is fully removed while protecting healthy tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of skin or soft tissue cancer called DFSP or superficial squamous cell carcinoma (sSCC).
- The tumor is on your head, arms, legs, or trunk (chest, back, or belly).
- You do not have an allergy to seafood or iodine (a substance used in the imaging).
- You do not have an overactive thyroid (hyperthyroidism).
- You are not pregnant.
- You do not have myasthenia gravis (a muscle weakness condition) or very high blood pressure that is hard to control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special dye (ICG) seen during your surgery can help doctors better identify the edges of a tumor in bone or soft tissue. It may help ensure as much of the tumor is removed as safely as possible.
This Phase 2 study tests whether using a fluorescent dye during tumor surgery can help the surgical team better see where the tumor ends. It may help aim for complete removal and lower the chance of the tumor coming back.
This trial tests a special dye and imaging technique to help surgeons see and remove sarcoma tumors more completely. The goal is to reduce the chance that cancer cells are accidentally left behind during surgery.
This trial tests a special dye that helps surgeons see the edges of sarcoma tumors during surgery. It may help them remove all the cancer while saving healthy tissue.
This trial tests a dye called indocyanine green (ICG) that makes cancer cells glow under a special camera during surgery. It may help doctors remove more cancer and leave healthy tissue alone.
This trial uses a special dye (ICG) and a camera to help surgeons see the tumor better during surgery for giant cell tumors of bone in the arms or legs. The goal is to remove all of the tumor while saving as much healthy bone as possible.
Hear when a new Dermatofibrosarcoma Protuberans (DFSP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.